Leiping Wang
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 41
- Cancer Treatment and Pharmacology 22
- HER2/EGFR in Cancer Research 19
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 4
-
- Advanced Breast Cancer Therapies 14
- Co-authors
- Biyun Wang (55 shared papers)Jun Cao (39 shared papers)Xichun Hu (34 shared papers)Jian Zhang (22 shared papers)Zhonghua Tao (33 shared papers)Zun Man (9 shared papers)Xiaorong Dai (8 shared papers)Zhonghua Wang (10 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Oncotarget (6 papers)BMC Cancer (4 papers)Chemical Engineering Journal (3 papers)Cancer Research (3 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Leiping Wang
77 papers receiving 1.5k citations
Leiping Wang's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 454
- Cancer Research 217
- Renewable Energy, Sustainability and the Environment 131
- Pulmonary and Respiratory Medicine 224
- Molecular Biology 435
Countries citing papers authored by Leiping Wang
This map shows the geographic impact of Leiping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leiping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leiping Wang more than expected).
Fields of papers citing papers by Leiping Wang
This network shows the impact of papers produced by Leiping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leiping Wang. The network helps show where Leiping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Leiping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Breast cancer: pathogenesis and treatments Hit paper breakdown → | 2025 | 242 |
| 2 | 2021 | 146 | |
| 3 | 2011 | 110 | |
| 4 | 2018 | 71 | |
| 5 | 2014 | 58 | |
| 6 | 2021 | 51 | |
| 7 | 2016 | 51 | |
| 8 | 2017 | 49 | |
| 9 | 2014 | 37 | |
| 10 | 2020 | 34 | |
| 11 | 2016 | 32 | |
| 12 | 2015 | 32 | |
| 13 | 2017 | 31 | |
| 14 | 2021 | 28 | |
| 15 | 2018 | 26 | |
| 16 | 2020 | 25 | |
| 17 | 2024 | 25 | |
| 18 | 2022 | 22 | |
| 19 | 2017 | 22 | |
| 20 | 2015 | 21 |
About Leiping Wang
Leiping Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Materials Chemistry and Molecular Biology, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (22 papers), HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (14 papers), Breast Cancer Treatment Studies (9 papers), Advanced Photocatalysis Techniques (5 papers), Cancer Genomics and Diagnostics (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Oncology (454 citations), Cancer Research (217 citations), Renewable Energy, Sustainability and the Environment (131 citations), Pulmonary and Respiratory Medicine (224 citations) and Molecular Biology (435 citations). Leiping Wang has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Biyun Wang, Jun Cao, Xichun Hu, Jian Zhang, Zhonghua Tao, Zun Man, Xiaorong Dai, Zhonghua Wang, Dezhao Liu and Zhimin Shao. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, BMC Cancer, Chemical Engineering Journal and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.